Abstract

Retinal gene transfer with adeno-associated viral (AAV) vectors holds great promise for the treatment of inherited retinal degenerations (IRDs). One limit of AAV is its transfer capacity of about 5 kb, which can be expanded to about 9 kb, using dual AAV vectors. This strategy would still not suffice for treatment of IRDs such as Usher syndrome type 1D or Alström syndrome type I (ALMS) due to mutations in CDH23 or ALMS1, respectively. To overcome this limitation, we generated triple AAV vectors, with a maximal transfer capacity of about 14 kb. Transcriptomic analysis following triple AAV transduction showed the expected full-length products along a number of aberrant transcripts. However, only the full-length transcripts are efficiently translated in vivo. We additionally showed that approximately 4% of mouse photoreceptors are transduced by triple AAV vectors and showed correct localization of recombinant ALMS1. The low-photoreceptor transduction levels might justify the modest and transient improvement we observe in the retina of a mouse model of ALMS. However, the levels of transduction mediated by triple AAV vectors in pig retina reached 40% of those observed with single vectors, and this bodes well for further improving the efficiency of triple AAV vectors in the retina.

Highlights

  • Inherited retinal degenerations (IRDs), with an overall global prevalence of 1/2,000,1 are a major cause of blindness worldwide

  • CDH23-3xflag and ALMS1-3xflag were split in three parts each cloned in a separate associated viral (AAV) vector (Figures 1C and 1D and Materials and Methods) from here called CDH-AAV 1, CDH-AAV 2, CDH-AAV 3, and Alström syndrome (ALMS)-AAV 1, ALMS-AAV 2, ALMS-AAV 3

  • While AAV-mediated gene therapy is effective in animal models and in patients with inherited blinding conditions,[3,4,5,6,7,52] its application to diseases affecting the retina and requiring transfer of sequences larger than 5 kb is limited by the small cargo capacity of AAV

Read more

Summary

Introduction

Inherited retinal degenerations (IRDs), with an overall global prevalence of 1/2,000,1 are a major cause of blindness worldwide. Robust MYO7A reconstitution by dual AAV vectors was confirmed in the mouse retina by Dyka et al.,[27] while several examples of dual AAV systems for minidystrophin (CDS, 6.2 kb) expression in mouse muscle are available.[23,28] The efficacy of dual AAV vectors, with a maximum transfer capacity of around 9 kb, opens the venue for further expansion to triple AAV vectors with a theoretical transfer capacity of around 14 kb

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.